Patent AT-E401088-T1: [Translated] COMPOSITION OF A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND GEMCITABINE FOR THE TREATMENT OF CANCER
HealthData.Gov
Updated Oct 29, 2026
About this dataset
The present invention relates to a method of treating cancer in a patient comprising administering an effective amount of a Survivin antisense oligonucleotide in combination with an effective amount of an additional anti-cancer agent.
Data and resources (1)
- HTML
Official Data Source
Access the complete Patent AT-E401088-T1: [Translated] COMPOSITION OF A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND GEMCITABINE FOR THE TREATMENT OF CANCER on the official website.
Modified Dec 27, 2025